Differences

This shows you the differences between two versions of the page.

--- en:aktuelles:medizinalhanf [2021/04/17 21:08] – external edit 127.0.0.1
+++ en:aktuelles:medizinalhanf [2021/08/13 14:01] – sos
@@ Line 3: / Line 3: @@
 The proposed amendment to the Narcotics Act provides that cannabis medicinal products may in future be prescribed without an exceptional authorisation from the Federal Office of Public Health (FOPH).
-**Status:** The referendum period runs until July 8, 2021. It seems unlikely that a referendum will be filed against it. The Federal Council will then set the date of entry into force. Before that, it will have to amend the ordinances. After that, an exciting phase lasting several years will begin in which these new possibilities will be explored and evaluated. However, as long as the health insurance companies do not pay for such cannabis medicines (this will be discussed further in the coming years), only a few sick people will be able to afford these preparations.
+**Status:** The referendum deadline expired on July 8, 2021. The Federal Council must now adopt the relevant ordinances, after which this amendment to the law can enter into force (probably in 2022).
+After that, an exciting phase lasting several years will begin in which these new possibilities will be explored and evaluated. However, as long as the health insurance companies do not pay for such cannabis medicines (this will be discussed further in the coming years), only a few sick people will be able to afford these preparations.
 ===== Development =====
@@ Line 12: / Line 14: @@
   * On 8 December 2020, the National Council clearly approved the bill by 143 votes to 33 with 15 abstentions. All minority motions were rejected.
   * [[en:thc_recht/li890606|Winter 20/21: Consultations on medicinal hemp have begun]]
-  * In October 2020, the [[https://www.parlament.ch/de/organe/kommissionen/sachbereichskommissionen/kommissionen-sgk|Committee for Social Security and Health of the National Council (SGK-N)]] was the first commission to discuss the facilitation of cannabis medicinal products and approved this amendment to the BetmG very clearly with 22:3.
+  * In October 2020, the [[https://www.parlament.ch/de/organe/kommissionen/sachbereichskommissionen/kommissionen-sgk|Committee for Social Security and Health of the National Council (SGK-N)]] was the first commission to discuss the facilitation of cannabis medicinal products and approved this amendment to the NarcA very clearly with 22:3.
   * The discussion about easier access for sick people to products containing THC has been going on for several years. The Federal Council has adopted the dispatch on this amendment to the Narcotics Law and now the parliamentary discussions are beginning.
   * [[en:thc_recht/li880405|2020: Start of the debate on medical hemp use]]